acebutolol has been researched along with Adrenal Cancer in 2 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plouin, PF | 2 |
| Ménard, J | 2 |
| Corvol, P | 2 |
| Chatellier, G | 1 |
| Rougeot, MA | 1 |
| Comoy, E | 1 |
2 other studies available for acebutolol and Adrenal Cancer
| Article | Year |
|---|---|
Noradrenaline producing phaeochromocytomas with absent pressor response to beta-blockade.
Topics: Acebutolol; Adrenal Gland Neoplasms; Adult; Blood Pressure; Female; Heart Rate; Humans; Male; Middle | 1979 |
Plasma renin activity in phaeochromocytoma: effects of beta-blockade and converting enzyme inhibition.
Topics: Acebutolol; Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzy | 1988 |